SP1 and breast cancer: Lu et al. [61] identified that overexpression of CLDN6 inhibited the proliferation of breast cancer cells and demonstrated that this effect was mediated by the inhibition of ERK/Sp1/cyclin D1 and ERK/IL-8 signaling.